-
公开(公告)号:US09334256B2
公开(公告)日:2016-05-10
申请号:US14125928
申请日:2012-06-15
申请人: Xiujun Sun , Michael Tymianski
发明人: Xiujun Sun , Michael Tymianski
IPC分类号: C07D215/00 , C07D311/00 , C07D311/20 , C07D333/70 , C07D409/06 , C07D409/12 , C07D215/227 , C07D311/58
CPC分类号: C07D311/20 , C07D215/227 , C07D311/58 , C07D333/70 , C07D409/06 , C07D409/12
摘要: This invention relates to compounds that modulate TRPM7 protein activity and use of the same for treatment or prophylaxis of ischemia, cancer, pain or glaucoma.
摘要翻译: 本发明涉及调节TRPM7蛋白活性的化合物及其用于治疗或预防缺血,癌症,疼痛或青光眼的化合物。
-
公开(公告)号:US20110251182A1
公开(公告)日:2011-10-13
申请号:US12966871
申请日:2010-12-13
IPC分类号: A61K31/551 , A61K31/4725 , A61K31/4709 , C07D333/70 , A61K31/381 , C07D311/04 , A61K31/366 , C07D417/06 , A61K31/5415 , C07D413/10 , A61K31/5377 , A61P9/10 , A61P27/06 , A61P29/00 , A61P35/00 , C07D409/06
CPC分类号: A61K31/551 , A61K31/122 , A61K31/353 , A61K31/381 , A61K31/4245 , A61K31/427 , A61K31/428 , A61K31/433 , A61K31/4704 , A61K31/4709 , A61K31/4725 , A61K31/496 , C07D209/08 , C07D215/08 , C07D215/233 , C07D277/36 , C07D277/82 , C07D311/18 , C07D333/38 , C07D333/60 , C07D339/00 , C07D403/06 , C07D409/04 , C07D409/06 , C07D417/04 , C40B40/04 , G01N33/6872 , G01N2510/00
摘要: This invention relates to methods of screening for modulators of mammalian cell injury cause by TRPM7 gene and protein activity, compounds that modulate TRPM7 gene and protein activity and methods of treatment of mammalian cell injury using modulators of TRPM7 gene and protein activity.
摘要翻译: 本发明涉及使用TRPM7基因和蛋白质活性的调节剂筛选TRPM7基因和蛋白质活性引起的哺乳动物细胞损伤调节剂,调节TRPM7基因的化合物和蛋白质活性的方法以及哺乳动物细胞损伤治疗方法。
-
公开(公告)号:US20140221423A1
公开(公告)日:2014-08-07
申请号:US14125928
申请日:2012-06-15
申请人: Xiujun Sun , Michael Tymianski
发明人: Xiujun Sun , Michael Tymianski
IPC分类号: C07D311/20 , C07D311/58 , C07D215/227
CPC分类号: C07D311/20 , C07D215/227 , C07D311/58 , C07D333/70 , C07D409/06 , C07D409/12
摘要: This invention relates to compounds that modulate TRPM7 protein activity and use of the same for treatment or prophylaxis of ischemia, cancer, pain or glaucoma.
摘要翻译: 本发明涉及调节TRPM7蛋白活性的化合物及其用于治疗或预防缺血,癌症,疼痛或青光眼的化合物。
-
公开(公告)号:US08680137B2
公开(公告)日:2014-03-25
申请号:US12966871
申请日:2010-12-13
IPC分类号: A01N43/12 , A61K31/38 , A01N43/06 , C07D333/00 , C07D311/02
CPC分类号: A61K31/551 , A61K31/122 , A61K31/353 , A61K31/381 , A61K31/4245 , A61K31/427 , A61K31/428 , A61K31/433 , A61K31/4704 , A61K31/4709 , A61K31/4725 , A61K31/496 , C07D209/08 , C07D215/08 , C07D215/233 , C07D277/36 , C07D277/82 , C07D311/18 , C07D333/38 , C07D333/60 , C07D339/00 , C07D403/06 , C07D409/04 , C07D409/06 , C07D417/04 , C40B40/04 , G01N33/6872 , G01N2510/00
摘要: This invention relates to methods of screening for modulators of mammalian cell injury cause by TRPM7 gene and protein activity, compounds that modulate TRPM7 gene and protein activity and methods of treatment of mammalian cell injury using modulators of TRPM7 gene and protein activity.
摘要翻译: 本发明涉及使用TRPM7基因和蛋白质活性的调节剂筛选TRPM7基因和蛋白质活性引起的哺乳动物细胞损伤调节剂,调节TRPM7基因的化合物和蛋白质活性的方法以及哺乳动物细胞损伤治疗方法。
-
-
-